Horizon Kinetics’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Horizon Kinetics’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-27	Closed	-$39K	–	515
2015 Q3	$39K	Hold	27	–	–	﹤0.01%	497
2015 Q2	$59K	Hold	27	–	–	﹤0.01%	513
2015 Q1	$80K	Hold	27	–	–	﹤0.01%	511
2014 Q4	$89K	Hold	27	–	–	﹤0.01%	509
2014 Q3	$95K	Hold	27	–	–	﹤0.01%	509
2014 Q2	$103K	Hold	27	–	–	﹤0.01%	519
2014 Q1	$109K	Hold	27	–	–	﹤0.01%	520
2013 Q4	$100K	Hold	27	–	–	﹤0.01%	530
2013 Q3	$106K	Hold	27	–	–	﹤0.01%	527
2013 Q2	$264K	Buy	+27	New	+$299K	﹤0.01%	378

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Horizon Kinetics's FRTX Position: Q4 2015 in Review

Horizon Kinetics sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2015, closing a stake of 27 shares — an estimated $39K sold.

Horizon Kinetics first reported a position in FRTX in Q2 2013 and held it in 10 quarters. The position peaked at $264K in Q2 2013. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

Horizon Kinetics reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
Horizon Kinetics sold 27 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $39K.
Horizon Kinetics first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 10 quarters.
Horizon Kinetics's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $264K in Q2 2013.
41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Horizon Kinetics's 13F filing for Q4 2015, filed 12 Feb 2016.